Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Inflammatory Bowel Diseases|August 10, 2011
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter studyM Barreiro-de Acosta, O García-Bosch, R Souto, et al.Human Immunology|October 15, 2013
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximabL M Medrano, C Taxonera, A Márquez, et al.Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.Alimentary Pharmacology & Therapeutics|December 7, 2011
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyM Chaparro, P Burgueño, E Iglesias, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2021
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE studyG Bastida, I Marín-Jiménez, A Forés, et al.Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.Journal of Crohn'S & Colitis|January 24, 2016
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of RetreatmentD Carpio, A Jauregui-Amezaga, R de Francisco, et al.Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.Pageof 3